Benjamin M Greenberg
Overview
Explore the profile of Benjamin M Greenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
1805
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nguyen L, Strozzi I, Hegde S, Greenberg B
Pediatr Neurol
. 2025 Feb;
165:40-42.
PMID: 39947012
Background: Glial fibrillary acid protein (GFAP) astrocytopathy is an autoimmune central nervous system disorder that rarely affects children. We describe a case of GFAP astrocytopathy with associated rhabdomyolysis in a...
2.
Kayani S, BordesEdgar V, Lowden A, Nettesheim E, Dahshi H, Messahel S, et al.
Orphanet J Rare Dis
. 2024 Dec;
19(1):468.
PMID: 39702211
Background: This study evaluated the clinical characteristics of neuronal ceroid lipofuscinosis type 7 or CLN7 disease spectrum to characterize the clinical, electrophysiologic and neuroimaging phenotypes. Methods: We performed a single-center...
3.
Thandla S, Armstrong G, Menon A, Shah A, Gueye D, Harb C, et al.
BioData Min
. 2024 Dec;
17(1):58.
PMID: 39696442
Introduction: The transformative feature of Artificial Intelligence (AI) is the massive capacity for interpreting and transforming unstructured data into a coherent and meaningful context. In general, the potential that AI...
4.
Nguyen L, Singh S, Feltrin F, Tardo L, Clarke R, Wang C, et al.
Mult Scler J Exp Transl Clin
. 2024 Aug;
10(3):20552173241274610.
PMID: 39148657
Background: Myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) is a relatively new disease entity in the field of demyelinating disorders. Its first diagnostic criteria have recently been published. Objectives: We...
5.
Kayani S, Bordes Edgar V, Lowden A, Nettesheim E, Dahshi H, Messahel S, et al.
Res Sq
. 2024 Jul;
PMID: 38978590
Background: This study evaluated the clinical characteristics of neuronal ceroid lipofuscinosis type 7 or CLN7 disease spectrum to characterize the clinical, electrophysiologic and neuroimaging phenotypes. Methods: We performed a single-center...
6.
Dowling J, Pirovolakis T, Devakandan K, Stosic A, Pidsadny M, Nigro E, et al.
Nat Med
. 2024 Jun;
30(7):1882-1887.
PMID: 38942994
There are more than 10,000 individual rare diseases and most are without therapy. Personalized genetic therapy represents one promising approach for their treatment. We present a road map for individualized...
7.
Smith C, Telesford K, Piccirillo S, Licon-Munoz Y, Zhang W, Tse K, et al.
J Neuroinflammation
. 2024 Jun;
21(1):161.
PMID: 38915059
Background: Pediatric acute transverse myelitis (ATM) accounts for 20-30% of children presenting with a first acquired demyelinating syndrome (ADS) and may be the first clinical presentation of a relapsing ADS...
8.
Iannaccone S, Cai C, Rhem B, Batley K, Rajaram V, Greenberg B, et al.
J Neurol
. 2024 Jun;
271(8):5659-5664.
PMID: 38907024
No abstract available.
9.
Nguyen L, Wang C, Hernandez R, Greenberg B
Mult Scler Relat Disord
. 2024 Feb;
84:105497.
PMID: 38364768
Background: Prognostic markers for relapse and neurological disability following the first clinical event in children with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) remain lacking. We investigated the clinical profiles and...
10.
Ren J, Dewey 3rd R, Rynders A, Evan J, Evan J, Ligozio S, et al.
J Nanobiotechnology
. 2024 Jan;
22(1):16.
PMID: 38167088
No abstract available.